- Home
- NIVF vs BDRX Comparison
NIVF vs BDRX Comparison
Compare NIVF & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIVF
- BDRX
- Stock Information
- Founded
- NIVF 2011
- BDRX 2000
- Country
- NIVF Thailand
- BDRX United Kingdom
- Employees
- NIVF N/A
- BDRX N/A
- Industry
- NIVF
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- NIVF
- BDRX Health Care
- Exchange
- NIVF NYSE
- BDRX Nasdaq
- Market Cap
- NIVF 2.1M
- BDRX 5.8M
- IPO Year
- NIVF N/A
- BDRX N/A
- Fundamental
- Price
- NIVF $0.62
- BDRX $0.87
- Analyst Decision
- NIVF
- BDRX
- Analyst Count
- NIVF 0
- BDRX 0
- Target Price
- NIVF N/A
- BDRX N/A
- AVG Volume (30 Days)
- NIVF 3.8M
- BDRX 3.1M
- Earning Date
- NIVF 01-01-0001
- BDRX 04-11-2025
- Dividend Yield
- NIVF N/A
- BDRX N/A
- EPS Growth
- NIVF N/A
- BDRX N/A
- EPS
- NIVF N/A
- BDRX N/A
- Revenue
- NIVF $5,433,375.00
- BDRX N/A
- Revenue This Year
- NIVF N/A
- BDRX N/A
- Revenue Next Year
- NIVF N/A
- BDRX N/A
- P/E Ratio
- NIVF N/A
- BDRX N/A
- Revenue Growth
- NIVF 5.79
- BDRX N/A
- 52 Week Low
- NIVF $0.61
- BDRX $0.78
- 52 Week High
- NIVF $656.00
- BDRX $41.50
- Technical
- Relative Strength Index (RSI)
- NIVF 27.45
- BDRX 38.67
- Support Level
- NIVF $0.61
- BDRX $0.85
- Resistance Level
- NIVF $1.24
- BDRX $0.92
- Average True Range (ATR)
- NIVF 0.12
- BDRX 0.06
- MACD
- NIVF 0.03
- BDRX 0.01
- Stochastic Oscillator
- NIVF 2.36
- BDRX 32.73
About NIVF NEWGENIVF GROUP LIMITED
NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.